Y10S 977/799
Containing biological material
Y10S977/799 (Containing biological material) appears on 150 US grants and 72 published applications in this corpus.
Search patents in Y10S- Granted patents
- 150
- Published applications
- 72
- Assignees
- 98
- Inventors
- 265
- Latest grant
- 14 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 9 | 0 |
| 1997 | 3 | 0 |
| 1998 | 18 | 0 |
| 1999 | 13 | 0 |
| 2000 | 22 | 0 |
| 2001 | 16 | 3 |
| 2002 | 13 | 8 |
| 2003 | 16 | 14 |
| 2004 | 3 | 6 |
| 2005 | 1 | 9 |
| 2006 | 2 | 3 |
| 2007 | 1 | 4 |
| 2008 | 3 | 1 |
| 2009 | 1 | 6 |
| 2010 | 1 | 3 |
| 2011 | 7 | 4 |
| 2012 | 1 | 3 |
| 2013 | 2 | 0 |
| 2014 | 4 | 1 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR14 Jan 2025US 12,195,505 B2Translate Bio, Inc.
- Nanolipoprotein particles comprising hydrogenases and related products, methods and systems27 Jun 2017US 9,688,718 B2Lawrence Livermore National Security, LLC
- Nanolipoprotein particles and related methods and systems for protein capture, solubilization, and/or purification4 Oct 2016US 9,458,191 B2Lawrence Livermore National Security, LLC
- Charge triggering of self-organized nanoparticles20 Oct 2015US 9,161,993 B2Danmarks Tekniske Universitet
- Nanolipoprotein particles and related methods and systems for protein capture, solubilization, and/or purification9 Dec 2014US 8,907,061 B2Lawrence Livermore National Security, LLC
- Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr19 Jun 2025US 2025/0197463 A1Translate Bio, Inc.
- Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr13 Oct 2022US 2022/0324926 A1Translate Bio, Inc.
- Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr21 May 2020US 2020/0157157 A1Translate Bio, Inc.
- Peptide Containing Porphyrin Lipid Nanovesicles11 May 2017US 2017/0128591 A1University Health Network
- Self-assembling nanoparticle drug delivery system4 May 2017US 2017/0119689 A1
Most cited
By later US patents
- Intradermal drug delivery device and method for intradermal delivery of drugs690US 5,848,991 AElan Medical Technologies Limited Athlone, Co. · 1998
- Therapeutic drug delivery systems498US 5,580,575 AImaRx Pharmaceutical Corp. · 1996
- Means to achieve sustained release of synergistic drugs by conjugation378US 6,051,576 AUniversity of Kentucky Research Foundation · 2000
- Methods of preparing gas-filled liposomes362US 5,469,854 AImaR.sub.x Pharmaceutical Corp. · 1995
- Process for preparing therapeutic compositions containing nanoparticles359US 5,510,118 ANanoSystems L.L.C. · 1996